20 hours ago Corporate Headquarters 2700 Van Buren Avenue Eagleville, PA 19403 Phone: (800) 487-9135 Fax: (610) 650-9272 >> Go To The Portal
STIC Intra-Compartmental Pressure Monitor The STIC Intra-Compartmental Pressure Monitor System is a convenient, self-contained, and reliable unit for quick and continuous readings of compartment pressure A timely and accurate diagnosis of compartment syndrome is critical to your patient outcomes.
Reinforced by decades of clinical evidence support, the STIC Pressure Monitor is the product you can rely on. “Compartment pressures are a vital adjunct for diagnosis. Measuring has little risk; not measuring can lead to permanent deformity and dysfunction.” Quick and simple application for definitive pressure measurements and a timely diagnosis.
Management of Serous Tubal Intraepithelial Carcinoma (STIC) Management of Serous Tubal Intraepithelial Carcinoma (STIC)
When an isolated STIC is identified a referral should be made to BC Cancer for consideration of completion surgical staging (minimum washings, omentectomy, directed biopsies, +/- hysterectomy).
The STIC Intra-Compartmental Pressure Monitor System from C2Dx delivers timely and accurate diagnosis of compartment syndrome. Its ease of use is demonstrated below as well as in the product manual.
To learn more about C2Dx products and how to use them, visit the Manuals page.
We provide full service, outpatient diagnostic imaging and interventional radiology services in San Antonio, Texas.
South Texas Radiology Imaging Centers offer dedicated women’s imaging centers with a full complement of screening, diagnostic and interventional services.
We provide full service, outpatient diagnostic imaging and interventional radiology services in San Antonio, Texas.
South Texas Radiology Imaging Centers offer dedicated women’s imaging centers with a full complement of screening, diagnostic and interventional services.
We provide full service, outpatient diagnostic imaging and interventional radiology services in San Antonio, Texas.
When performing a risk reducing bilateral BSO for women with a BRCA1 or BRCA2 mutation, a STIC will be found in approximately 3.5-5.5% of patients 34, 35, 36. In women having an opportunistic salpingectomy for benign disease or in women with a high risk family history, STIC may be found in approximately 0.6-1.1% of patients.
Approximately 4.5% of high-risk women (with BRCA1 or BRCA2 mutations) with a STIC will later develop of primary peritoneal carcinoma, and the median time to the development 4-6 years. Only women with invasive disease found at the time of completion surgery should be offered post-operative chemotherapy.